Caplin Point Laboratories balance sheet

As of Mar 2026

Total assets: ₹4,045cr+26.1% on Mar 2025
Shareholders' equity: ₹3,631cr+25.8% on Mar 2025
Total debt: ₹0.6cr+3.6% on Mar 2025
Cash and investments: ₹480cr−6.0% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	547	530	439	267
	209	139	117	220
	32.5	11.3	12.5	10.9
	25.0	4.3	0.0	0.2
	473	279	138	70.5
	28.4	22.2	12.6	4.2
	502	279	150	74.7
	8.0	2.2	12.2	13.9
	137	110	75.0	49.7
	1,460	1,075	805	637
	429	336	363	288
	386	311	238	159
	826	632	543	394
	94.2	199	139	178
	527	392	414	316
	74.2	57.4	45.5	71.9
	1,907	1,593	1,379	1,119
	250	205	150	148
	2,586	2,134	1,892	1,554
	4,045	3,209	2,697	2,191
Equity
	15.2	15.2	15.2	15.2
	3,571	2,835	2,301	1,865
	3,586	2,850	2,316	1,880
	44.4	35.9	31.1	26.8
	3,631	2,886	2,347	1,907
Liabilities
	0.0	0.0	0.9	0.0
	2.1	2.9	10.5	0.9
	2.1	2.9	11.4	0.9
	1.0	1.3	8.6	7.8
	12.6	0.8	0.0	0.0
	13.1	10.8	0.0	7.4
	28.7	15.8	20.0	16.1
	0.6	0.6	0.3	3.4
	296	218	209	164
	52.7	45.3	74.9	72.5
	349	263	285	240
	20.0	24.0	10.3	0.3
	16.6	19.0	35.6	27.5
	386	306	331	268
	415	322	351	284
	4,045	3,209	2,697	2,191
Trade payables — MSME split
	9.3	2.3	—	—
	287	215	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

CAPLIPOINT₹2,376.10

Caplin Point Laboratories Ltd.

· Pharma & Health

₹ CrorePeersAJANTPHARM ERIS GLAND BLUEJET CONCORDBIO ACUTAAS EMCURE GRANULESMcap ₹18,058 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	267.0	438.6	530.3	547.5	547.5
+ Capital Work-in-Progress	220.5	116.6	139.2	208.6	208.6
+ Other Intangibles	10.9	12.5	11.3	32.5	32.5
+ Intangibles under Development	0.2	0.0	4.3	25.0	25.0
+ Non-current Investments	70.5	137.6	279.1	473.3	473.3
+ Other Non-current Financial Assets	4.2	12.6	22.2	28.4	28.4
Non-current Financial Assets	74.7	150.2	279.1	501.7	501.7
+ Deferred Tax Assets	13.9	12.2	2.2	8.0	8.0
+ Other Non-current Assets	49.7	75.0	110.4	136.6	136.6
Total Non-current Assets	636.9	805.2	1,074.6	1,459.8	1,459.8
Current Assets
+ Inventories	288.2	363.0	336.1	428.9	428.9
+ Current Investments	159.2	238.0	311.3	385.7	385.7
+ Trade Receivables	394.1	542.7	632.5	825.8	825.8
+ Cash & Cash Equivalents	177.6	138.7	199.5	94.2	94.2
+ Other Bank Balances	315.9	414.0	392.0	526.9	526.9
+ Other Current Financial Assets	71.9	45.5	57.4	74.2	74.2
Current Financial Assets	1,118.6	1,379.0	1,592.6	1,906.7	1,906.7
+ Other Current Assets	147.6	150.2	205.3	250.1	250.1
Total Current Assets	1,554.5	1,892.2	2,134.0	2,585.7	2,585.7
Total Assets	2,191.4	2,697.4	3,208.6	4,045.5	4,045.5
Equity
+ Equity Share Capital	15.2	15.2	15.2	15.2	15.2
+ Other Equity / Reserves	1,865.3	2,300.5	2,835.3	3,571.2	3,571.2
Equity — Owners of Parent	1,880.5	2,315.7	2,850.5	3,586.4	3,586.4
+ Minority Interest	26.8	31.1	35.9	44.4	44.4
Total Equity	1,907.3	2,346.8	2,886.4	3,630.8	3,630.8
Liabilities
+ Borrowings — Non-current	0.0	0.9	0.0	0.0	0.0
+ Other Non-current Financial Liab	0.9	10.5	2.9	2.1	2.1
Non-current Financial Liabilities	0.9	11.4	2.9	2.1	2.1
+ Provisions — Non-current	7.8	8.6	1.3	1.0	1.0
+ Deferred Tax Liabilities	0.0	0.0	0.8	12.6	12.6
+ Other Non-current Liabilities	7.4	0.0	10.8	13.1	13.1
Non-current Liabilities	16.1	20.0	15.8	28.7	28.7
+ Borrowings — Current	3.4	0.3	0.6	0.6	0.6
+ Trade Payables	164.4	209.4	217.6	296.0	296.0
+ Other Current Financial Liab	72.5	74.9	45.3	52.7	52.7
Current Financial Liabilities	240.3	284.6	263.4	349.3	349.3
+ Provisions — Current	0.3	10.3	24.0	20.0	20.0
+ Other Current Liabilities	27.5	35.6	19.0	16.6	16.6
Current Liabilities	268.0	330.6	306.4	385.9	385.9
Total Liabilities	284.1	350.6	322.2	414.7	414.7
Total Equity & Liabilities	2,191.4	2,697.4	3,208.6	4,045.5	4,045.5
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	2.3	9.3	9.3
+ Dues to Other Creditors — Current	—	—	215.3	286.8	286.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.